Skin appears more sculpted, lifted, vibrant, and renewed
NICE guideline NG28 recommends individualised HbA1c targets for people with type 2 diabetes, typically aiming for 48 mmol/mol (6.5%) or lower for most adults on lifestyle interventions or a single drug not associated with hypoglycaemia
Hadidchis expertise in personalized care will ensure you understand what to expect and how to get the most out of your treatment
Conservative starting doses would be essential: Initial phase : Cagrilintide 0.3 mg + Tirzepatide 2.5 mg weekly Escalation : Increase cagrilintide by 0.3-0.6 mg every 4 weeks Tirzepatide adjustment : Maintain or modestly increase based on tolerance Monitoring : Close observation for cumulative GI effects This remains speculative, as no published trials have examined this specific combination
Early in therapy , daily communication or journaling may be advised to help manage side effects or behavioral changes
Most people deep in the GLP-1 research rabbit hole know about semaglutide injections such as Ozempic for type 2 diabetes and Wegovy for weight loss